Idiopathic anaphylaxis.
Bilò MB, Martini M, Tontini C, Mohamed OE, Krishna MT.
Clin Exp Allergy. 2019 Jul;49(7):942-952. doi: 10.1111/cea.13402. Epub 2019 May 13.
Histamine and schizophrenia.
Arrang JM.
Int Rev Neurobiol. 2007;78:247-87. doi: 10.1016/S0074-7742(06)78009-6.
H2-receptor antagonists.
Ivey KJ.
Int J Dermatol. 1980 May;19(4):175-81. doi: 10.1111/j.1365-4362.1980.tb00294.x.
Hepatotoxic and hepatoprotective potential of histamine (H2)-receptor antagonists.
Black M.
Am J Med. 1987 Dec 18;83(6A):68-75. doi: 10.1016/0002-9343(87)90814-x.
Cimetidine-induced dystonic reaction.
Peiris RS, Peckler BF.
J Emerg Med. 2001 Jul;21(1):27-9. doi: 10.1016/s0736-4679(01)00325-0.
Two distinct pathways for histamine H2 receptor down-regulation. H2 Leu124 --> Ala receptor mutant provides evidence for a cAMP-independent action of H2 agonists.
Smit MJ, Roovers E, Timmerman H, van de Vrede Y, Alewijnse AE, Leurs R.
J Biol Chem. 1996 Mar 29;271(13):7574-82. doi: 10.1074/jbc.271.13.7574.
Efficacy of a selective histamine H2 receptor agonist, dimaprit, in experimental models of endotoxin shock and hepatitis in mice.
Nakamura T, Ueno Y, Goda Y, Nakamura A, Shinjo K, Nagahisa A.
Eur J Pharmacol. 1997 Mar 12;322(1):83-9. doi: 10.1016/s0014-2999(96)00987-9.
Ranitidine.
[No authors listed]
N Engl J Med. 1984 Jun 14;310(24):1601-6. doi: 10.1056/NEJM198406143102412.
Effect of histamine H2 receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson's disease.
Johnston TH, van der Meij A, Brotchie JM, Fox SH.
Mov Disord. 2010 Jul 30;25(10):1379-90. doi: 10.1002/mds.23069.
Multiple signaling pathways of histamine H2 receptors. Identification of an H2 receptor-dependent Ca2+ mobilization pathway in human HL-60 promyelocytic leukemia cells.
Mitsuhashi M, Mitsuhashi T, Payan DG.
J Biol Chem. 1989 Nov 5;264(31):18356-62.
